Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Vickerman

Showing results (111-120 of 397) with videos related to

Pageof 40
Sort By:
AIDS (London, England)|October 28, 2022
Impact and cost-effectiveness of non-governmental organizations on the HIV epidemic in Ukraine among MSMAdam Trickey, Josephine G Walker, Sandra Bivegete, et al.
Drug and Alcohol Dependence|September 25, 2018
Usage of low dead space syringes and association with hepatitis C prevalence amongst people who inject drugs in the UKAdam Trickey, Margaret T May, Vivian Hope, et al.
Addiction (Abingdon, England)|October 22, 2019
Detachable low dead space syringes for the prevention of hepatitis C among people who inject drugs in Bristol, UK: an economic evaluationElizabeth Hancock, Zoe Ward, Rachel Ayres, et al.
The International Journal on Drug Policy|February 16, 2022
Perceived availability and carriage of take-home naloxone and factors associated with carriage among people who inject drugs in England, Wales and Northern IrelandChristiane Spring, Sara Croxford, Zoe Ward, et al.
Hepatology (Baltimore, Md.)|September 8, 2011
Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populationsNatasha K Martin, Peter Vickerman, Alec Miners, et al.
Drug and Alcohol Dependence|March 5, 2013
Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission?Peter Vickerman, Natasha K Martin, Anuradha Roy, et al.
BMJ Open|June 30, 2016
Preferences for ARV-based HIV prevention methods among men and women, adolescent girls and female sex workers in Gauteng Province, South Africa: a protocol for a discrete choice experimentMatthew Quaife, Robyn Eakle, Maria Cabrera, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 28, 2019
Hepatitis C virus elimination in Indonesia: Epidemiological, cost and cost-effectiveness modelling to advance advocacy and strategic planningAdam Trickey, Lindsey Hiebert, Chase Perfect, et al.
AIDS (London, England)|February 2, 2023
Economic evaluation of improving HIV self-testing among MSM in China using a crowdsourced intervention: a cost-effectiveness analysisJason J Ong, Ross D Booton, Joseph D Tucker, et al.
The Lancet. HIV|October 3, 2025
The impact of cuts in the US President's Emergency Plan for AIDS Relief funding for HIV pre-exposure prophylaxis in sub-Saharan Africa: a modelling studyJack Stone, Kennedy Kipkoech Mutai, Adelina Artenie, et al.
Pageof 40

Showing results (111-120 of 397) with videos related to

Sort By:
Pageof 40
AIDS (London, England)|October 28, 2022
Impact and cost-effectiveness of non-governmental organizations on the HIV epidemic in Ukraine among MSMAdam Trickey, Josephine G Walker, Sandra Bivegete, et al.
Drug and Alcohol Dependence|September 25, 2018
Usage of low dead space syringes and association with hepatitis C prevalence amongst people who inject drugs in the UKAdam Trickey, Margaret T May, Vivian Hope, et al.
Addiction (Abingdon, England)|October 22, 2019
Detachable low dead space syringes for the prevention of hepatitis C among people who inject drugs in Bristol, UK: an economic evaluationElizabeth Hancock, Zoe Ward, Rachel Ayres, et al.
The International Journal on Drug Policy|February 16, 2022
Perceived availability and carriage of take-home naloxone and factors associated with carriage among people who inject drugs in England, Wales and Northern IrelandChristiane Spring, Sara Croxford, Zoe Ward, et al.
Hepatology (Baltimore, Md.)|September 8, 2011
Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populationsNatasha K Martin, Peter Vickerman, Alec Miners, et al.
Drug and Alcohol Dependence|March 5, 2013
Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission?Peter Vickerman, Natasha K Martin, Anuradha Roy, et al.
BMJ Open|June 30, 2016
Preferences for ARV-based HIV prevention methods among men and women, adolescent girls and female sex workers in Gauteng Province, South Africa: a protocol for a discrete choice experimentMatthew Quaife, Robyn Eakle, Maria Cabrera, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 28, 2019
Hepatitis C virus elimination in Indonesia: Epidemiological, cost and cost-effectiveness modelling to advance advocacy and strategic planningAdam Trickey, Lindsey Hiebert, Chase Perfect, et al.
AIDS (London, England)|February 2, 2023
Economic evaluation of improving HIV self-testing among MSM in China using a crowdsourced intervention: a cost-effectiveness analysisJason J Ong, Ross D Booton, Joseph D Tucker, et al.
The Lancet. HIV|October 3, 2025
The impact of cuts in the US President's Emergency Plan for AIDS Relief funding for HIV pre-exposure prophylaxis in sub-Saharan Africa: a modelling studyJack Stone, Kennedy Kipkoech Mutai, Adelina Artenie, et al.
Pageof 40